|
| 37230869 | Bone health and menopause: Osteoporosis prevention and treatment. | | 2023 |
| 35041568 | Bone health 2022: an update. | Climacteric | 2022 |
| 34036859 | Premenopausal osteoporosis. | Climacteric | 2022 |
| 34498505 | Update on bone health: the International Menopause Society White Paper 2021. | Climacteric | 2021 |
| 34240674 | Using menopausal hormone therapy to prevent fracture recurrence in older women: is it time to change our opinion? | Climacteric | 2021 |
| 33996429 | Osteoporosis management in hematologic stem cell transplant recipients: Executive summary. | | 2021 |
| 33606045 | Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis. | Osteoporosis International | 2021 |
| 34190361 | Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial. | Journal of Bone and Mineral Research | 2021 |
| 32553680 | Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis. | J Am Acad Dermatol | 2021 |
| 32119749 | Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension. | Journal of Bone and Mineral Research | 2020 |
| 31294631 | Effects of ospemifene on bone in postmenopausal women. | Climacteric | 2019 |
| 31676222 | Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. | Lancet Diabetes Endocrinol | 2019 |
| 29447485 | Should women be screened for osteoporosis at midlife? | Climacteric | 2018 |
| 30178158 | Bone management in hematologic stem cell transplant recipients. | Osteoporosis International | 2018 |
| 28286990 | The quest for new drugs to prevent osteoporosis-related fractures. | Climacteric | 2017 |
| 28413771 | Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. | | 2017 |
| 26669628 | Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy. | Climacteric | 2016 |
| 27389038 | Revised global consensus statement on menopausal hormone therapy. | Maturitas | 2016 |
| 27327421 | Cardiovascular risk assessment in women - an update. | Climacteric | 2016 |
| 27322027 | Revised Global Consensus Statement on Menopausal Hormone Therapy. | Climacteric | 2016 |
| 26556736 | A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates. | Osteoporosis International | 2016 |
| 26474003 | The role of menopausal hormone therapy in the management of osteoporosis. | Climacteric | 2015 |
| 25335119 | The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy. | Climacteric | 2015 |
| 25668306 | A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture. | Menopause | 2015 |
| 25627565 | In memoriam: Stephen Hough 27/08/1947-05/12/2014. | Journal of Bone and Mineral Research | 2015 |
| 25242261 | 8th Pieter van Keep Memorial Lecture. Estrogen and bone: have we completed a full circle? | Climacteric | 2014 |
| 24363446 | Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study. | Journal of the National Cancer Institute | 2014 |
| 25213840 | South African Menopause Society revised consensus position statement on menopausal hormone therapy, 2014. | South African Medical Journal | 2014 |
| 24571030 | Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures. | Climacteric | 2014 |
| 25118550 | The safety of osteoporosis medication. | South African Medical Journal | 2014 |
| 24568708 | Case 203: Gorham disease. | Radiology | 2014 |
| 24654673 | Risks and benefits of hormone therapy: has medical dogma now been overturned? | Climacteric | 2014 |
| 24969415 | Prevention of diseases after menopause. | Climacteric | 2014 |
| 23497918 | Global Consensus Statement on menopausal hormone therapy. | Maturitas | 2013 |
| 24146095 | Cancer-associated bone disease. | Osteoporosis International | 2013 |
| 24064689 | Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial. | Journal of Clinical Endocrinology and Metabolism | 2013 |
| 23931571 | Oncology in midlife and beyond. | Climacteric | 2013 |
| 23871271 | Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study. | | 2013 |
| 23488524 | Global consensus statement on menopausal hormone therapy. | Climacteric | 2013 |
| 23672656 | Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. | Climacteric | 2013 |
| 22066790 | Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms. | Climacteric | 2012 |
| 22344196 | Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. | J Clin Endocrinol Metab | 2012 |
| 22343510 | Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. | Menopause | 2012 |
| 22341880 | Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. | Fertil Steril | 2012 |
| 22338612 | Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. | Climacteric | 2012 |
| 22612613 | The WHI: the effect of hormone replacement therapy on fracture prevention. | Climacteric | 2012 |
| 23281547 | Improved management of patients with osteoporosis. | South African Medical Journal | 2012 |
| 21331467 | Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5Â mg. | Osteoporosis International | 2012 |
| 21880430 | Tactical treatment with copper oxide wire particles and symptomatic levamisole treatment using the FAMACHA(©) system in indigenous goats in South Africa. | Veterinary Parasitology | 2012 |
| 22016894 | Calcium supplements and the risk of cardiovascular events. | Climacteric | 2011 |